A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
FDA and USDA again confirm that country’s commercial milk supply is safe, amid recent string of bird flu cases in US dairy herds
Published:
April 24, 2024
by Dairy Processing
|
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published:
April 24, 2024
by GSK Group (GlaxoSmithKline)
|
Bimatoprost found to be the most effective and only FDA-approved ingredient for eyelash serums shown to increase eyelash length safely, according to a review in the Journal of Cosmetic Dermatology
Published:
April 22, 2024
by CosmeticsDesign.com (US)
|
FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published:
April 19, 2024
by Business Wire
|
Vanda Pharmaceuticals thwarts a hostile takeover bid from Future Pak by implementing a shareholder rights plan or 'poison pill' strategy; the bid follows FDA approval for the expansion of its antipsychotic drug Fanapt
Published:
April 19, 2024
by FiercePharma
|
Ask us about our Health Care Sector market view